Raymond James Financial
RLYB icon

Raymond James Financial’s Rallybio RLYB Stock Holding History

Raymond James Financial’s Portfolio RLYB Stock Details RLYB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-106
Closed -$288 – 6387
2025
Q2 		$288 Buy
+106
New +$281 ﹤0.01% 6741

Other funds holding RLYB

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIIC
AJU IB Investment Company Seoul, South Korea $30.5M AUM 128.96% 1-Year Est. Return

Raymond James Financial's RLYB Position: Q3 2025 in Review

Raymond James Financial sold out of Rallybio (RLYB) in Q3 2025, closing a stake of 106 shares — an estimated $288 sold.

Raymond James Financial first reported a position in RLYB in Q2 2025 and held it in 1 quarter. The position peaked at $288 in Q2 2025. 45 funds tracked by Wall St. Rank hold RLYB as of Q3 2025.

  • Raymond James Financial reported no remaining Rallybio position as of Q3 2025 after selling out during the quarter.
  • Raymond James Financial sold 106 Rallybio shares in Q3 2025, an estimated $288.
  • Raymond James Financial first reported a position in Rallybio in Q2 2025 and held it in 1 quarter.
  • Raymond James Financial's Rallybio position peaked at $288 in Q2 2025.
  • 45 funds tracked by Wall St. Rank held Rallybio as of Q3 2025.

Based on Raymond James Financial's 13F filing for Q3 2025, filed 14 Nov 2025.